Lemaitre Vascular INC Form 4 insider transactions

Senior VP of Operations at LeMaitre Vascular, Trent G. Kamke, reports the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations.

LeMaitre Vascular's Chief Financial Officer, Joseph P. Pellegrino Jr., reported the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations related to vested restricted stock units.

Lemaitre Vascular Inc.'s President and Director, David B. Roberts, acquired shares through the release of dividend equivalent rights, as part of a restricted stock unit vesting.

LeMaitre Vascular's CEO, George W. LeMaitre, acquired shares through the release of dividend equivalent rights and a tax withholding transaction.

LeMaitre Vascular's CEO, George W. LeMaitre, received stock options and restricted stock units as part of his compensation package.

Lemaitre Vascular Inc. grants stock options and restricted stock units to executive Martha Shadan.

Director John A. Roush of Lemaitre Vascular Inc. reported acquiring shares and stock options, while also disposing of some shares.

Director Bridget A. Ross acquired 420 shares of common stock and 2,594 stock options in Lemaitre Vascular, Inc.

Lemaitre Vascular Inc. has granted stock options and restricted stock units to executive John James O'Connor.

Director Lawrence J. Jasinski of Lemaitre Vascular, Inc. acquired 420 shares of common stock and 2,594 stock options on December 6, 2024.

Lemaitre Vascular Inc.'s Chief Financial Officer, Joseph P. Pellegrino Jr., received stock options and restricted stock units as part of his compensation package.

Lemaitre Vascular Inc. has granted stock options and restricted stock units to Senior Vice President of Operations, Trent G. Kamke.

David B. Roberts, President and Director of Lemaitre Vascular, acquired 1,335 shares of common stock and 7,662 stock options on December 6, 2024.

Director Martha Shadan of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.

Director John A. Roush of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.

Director Bridget A. Ross acquired dividend equivalent rights related to previously granted restricted stock units and performance share units in LeMaitre Vascular Inc.

Director John O'Connor acquired dividend equivalent rights related to previously granted stock awards in LeMaitre Vascular.

Director Lawrence J. Jasinski of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.

Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, acquired dividend equivalent rights related to previously granted stock awards.

Joseph P. Pellegrino Jr., CFO of Lemaitre Vascular, acquired dividend equivalent rights related to previously granted restricted stock units and performance share units.

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the acquisition of dividend equivalent rights related to previously granted stock awards.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, acquired dividend equivalent rights related to previously granted restricted stock units and performance share units.

Senior VP of Operations at Lemaitre Vascular, Trent G. Kamke, reports the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations.

LeMaitre Vascular's Chief Financial Officer, Joseph P. Pellegrino Jr., reported transactions involving common stock and dividend equivalent rights following the vesting of restricted stock units.

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the acquisition of 12 shares and the disposal of 106 shares of common stock on December 2, 2024.

LeMaitre Vascular's CEO, George W. LeMaitre, reports the acquisition of 32 shares and the disposal of 298 shares of common stock on December 2, 2024, related to dividend equivalent rights and tax obligations.

Director John James O'Connor exercised stock options to acquire 7,500 shares of Lemaitre Vascular Inc. common stock.

LeMaitre Vascular's CEO, George W. LeMaitre, exercised stock options, acquiring 2,818 shares of common stock.

A director at Lemaitre Vascular, Lawrence J. Jasinski, sold 198 shares of common stock at a price of $103.5 per share on November 20, 2024.

Director Bridget A. Ross exercised stock options and sold shares of Lemaitre Vascular Inc. on November 15, 2024.